Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 10,416.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,416.47% |
WW International, Inc Common Stock (WW) | 2,334.35% |
DeFi Development (DFDV) | 2,280.74% |
Diginex Limited Ordinary Shares (DGNX) | 1,320.19% |
FiEE (FIEE) | 1,138.53% |
Asset Entities Inc Class B Common Stock (ASST) | 1,130% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 1,031.11% |
Abivax SA American Depositary Shares (ABVX) | 1,019.2% |
Oncology Institute (TOI) | 1,011.11% |
Global Interactive Technologies (GITS) | 804.56% |
Airnet Technology (ANTE) | 801.49% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 756.27% |
ThredUp (TDUP) | 651.39% |
mF International Limited Ordinary Shares (MFI) | 606.21% |
SRM Entertainment, Inc Common Stock (SRM) | 587.72% |
Dominari (DOMH) | 581.67% |
Abits (ABTS) | 489.34% |
Immunoprecise Antibodies (IPA) | 478.05% |
Lizhi (SOGP) | 464.5% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 454.91% |
Newegg Commerce (NEGG) | 424.13% |
So-Young International (SY) | 390.36% |
I-Mab (IMAB) | 389.41% |
ABVC BioPharma (ABVC) | 379.66% |
Vigil Neuroscience (VIGL) | 373.53% |
